Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.

Suppr

超能文献

作者信息

Jacobs F, Mamzer-Bruneel M F, Skhiri H, Thervet E, Legendre C, Kreis H

出版信息

Transplantation. 1997 Oct 15;64(7):1087-8. doi: 10.1097/00007890-199710150-00027.

DOI:10.1097/00007890-199710150-00027

PMID:9381537

Abstract

摘要

相似文献

Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.

Transplantation. 1997 Oct 15;64(7):1087-8. doi: 10.1097/00007890-199710150-00027.

Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.

Nephron. 2002 May;91(1):173-4. doi: 10.1159/000057624.

Cyclosporine-induced hyperuricemia and gout in renal transplants.

Transplant Proc. 1995 Oct;27(5):2722-4.

Dermal tophus: a complication of gout in a kidney transplant recipient.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:276-9. doi: 10.6002/ect.mesot2014.p112.

[Allopurinol efficacy in patients with tophus gout and chronic renal failure].

Ter Arkh. 2006;78(6):88-91.

Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.

Am J Med. 2006 Nov;119(11 Suppl 1):S29-31. doi: 10.1016/j.amjmed.2006.06.027.

High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.

Transplant Proc. 2002 Nov;34(7):2983-4. doi: 10.1016/s0041-1345(02)03508-x.

Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia.

JAMA. 2018 Jan 9;319(2):188-189. doi: 10.1001/jama.2017.20189.

Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients.

Transplant Proc. 1998 Dec;30(8):4077-8. doi: 10.1016/s0041-1345(98)01347-5.

Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.

Transplant Proc. 2003 Nov;35(7):2752-3. doi: 10.1016/j.transproceed.2003.09.059.

引用本文的文献

Lowering and Raising Serum Urate Levels: Off-Label Effects of Commonly Used Medications.

Mayo Clin Proc. 2022 Jul;97(7):1345-1362. doi: 10.1016/j.mayocp.2022.02.027.

Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.

Arthritis Rheumatol. 2021 Aug;73(8):1523-1532. doi: 10.1002/art.41731. Epub 2021 May 19.

Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.

BMC Cancer. 2020 Mar 30;20(1):268. doi: 10.1186/s12885-020-06751-2.

Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients.

Drug Des Devel Ther. 2014 Feb 17;8:245-53. doi: 10.2147/DDDT.S56597. eCollection 2014.

[Asymptomatic nodule on an elderly lady's thumb tip].

Hautarzt. 2011 Mar;62(3):224-8. doi: 10.1007/s00105-010-2106-5.

Gout in solid organ transplantation: a challenging clinical problem.

Drugs. 2005;65(18):2593-611. doi: 10.2165/00003495-200565180-00004.

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Drug Saf. 2001;24(9):645-63. doi: 10.2165/00002018-200124090-00002.

Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Curr Rheumatol Rep. 2001 Feb;3(1):29-35. doi: 10.1007/s11926-001-0048-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验